Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

SCI-110 in the Treatment of Tourette Syndrome

To evaluate the efficacy, safety and tolerability of the cannabinoid-based medication SCI-110 compared to placebo in subjects with Tourette syndrome.

Participants needed: 164
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Neurothera Labs Inc.Updated: Apr 21, 2026Locations: 3
Eligibility criteria

Tourette syndrome according to Diagnostic and Statistical Manual of Mental Disor... [+11]

Comorbid obsessive-compulsive disorder (OCD), attention deficit/hyperactivity di... [+16]

Read more
Status: Recruiting

SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD)

To evaluate the safety and efficacy of SCI-210 in the treatment of Autism Spectrum Disorders (ASD)

Participants needed: 60
Trial details
Age: 5-18Biological sex: AllType: InterventionalSponsor: Neurothera Labs Inc.Updated: May 16, 2025Locations: 1
Eligibility criteria

Males or females aged between 5 and 18 years of age (inclusive) [+4]

Children who are already receiving cannabis, antipsychotic drugs, or stimulants. [+8]

Read more